Definium Therapeutics, Inc.
Company Stats
- Market Cap
- $5.1B
- as of Sep 30, 2026
- Enterprise Value
- $4.9B
- Shares Outstanding
- 134.4M
- Free Float
- 98.1%
Income Statement
- Operating Income
- -$166.3M
- Net Income
- -$183.8M
Balance Sheet
- Cash & Equivalents
- $257.8M
- Total Debt
- $41.0M
- Net Cash
- $216.8M
Returns & Capital
- SBC, 3Y Avg
- $17.4M
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges